Literature DB >> 11473952

Prediction of the potentially fertile period by urinary hormone measurements using a new home-use monitor: comparison with laboratory hormone analyses.

K Tanabe1, N Susumu, K Hand, K Nishii, I Ishikawa, S Nozawa.   

Abstract

BACKGROUND: The study compared a new urinary hormone monitoring system, Clearview Primera Fertility Monitor (CPFM), with laboratory hormone analyses in the prediction of the potentially fertile period.
METHODS: Thirty healthy female volunteers provided blood and early morning urine samples for one cycle. Serum oestradiol, progesterone and luteinizing hormone (LH), and urinary LH and oestrone-3-glucuronide (E3G) were measured. The fertility status of volunteers; Low, High or Peak, was collected from monitors and compared with the hormone measurements.
RESULTS: There was agreement between the first day of peak fertility and the urinary LH peak day in 65.6% of cycles and detection 1 or 2 days before the urinary LH peak day in 24.1 and 6.9% of cycles respectively. In 58.6% of cycles the system detected up to 5 days of increased fertility prior to the urinary LH peak day. Warning days of the urinary LH peak were similarly determined using defined thresholds of E3G and oestradiol providing up to 5 days warning in 82.8 and 96.6% of cycles respectively.
CONCLUSIONS: The system can provide couples attempting to conceive with information about the potentially fertile days in the cycle in order that they may time intercourse. It also has potential for use in evaluation and treatment of infertile couples.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473952     DOI: 10.1093/humrep/16.8.1619

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Personal fertility monitors for contraception.

Authors:  Thomas P Bouchard; Stephen J Genuis
Journal:  CMAJ       Date:  2010-11-15       Impact factor: 8.262

2.  Associations between urinary biomarkers of polycyclic aromatic hydrocarbon exposure and reproductive function during menstrual cycles in women.

Authors:  Ulrike Luderer; Fletcher Christensen; Wesley O Johnson; Jianwen She; Ho Sai Simon Ip; Junqiang Zhou; Josephine Alvaran; Edward F Krieg; James S Kesner
Journal:  Environ Int       Date:  2017-01-05       Impact factor: 9.621

3.  Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis.

Authors:  K Walker; D J Bratton; C Frost
Journal:  Br J Cancer       Date:  2011-09-13       Impact factor: 7.640

4.  A Novel Fertility Indicator Equation Using Estradiol Levels for Assessment of Phase of the Menstrual Cycle.

Authors:  Stephen J Usala; A Alexandre Trindade
Journal:  Medicina (Kaunas)       Date:  2020-10-22       Impact factor: 2.430

5.  Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase.

Authors:  Stephen J Usala; María Elena Alliende; A Alexandre Trindade
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.